MATTHEW AITCHISON: Open Payments
NPI 1902273931 · EL DORADO, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 74 payments from 16 companies in 2025. Trend: 2023 $1,355 · 2024 $1,094 · 2025 $1,092
Food & beverage: $1,059Education: $32
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $236 |
| PFIZER INC. | 22 | $164 |
| Lilly USA, LLC | 10 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $141 |
| Novo Nordisk Inc | 5 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $36 |
| Amgen Inc. | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
Products named: BREZTRI, Kerendia, MOUNJARO, NURTEC ODT, AIRSUPRA, Ozempic, CAPLYTA, GEMTESA.
Industry payments across KS — which companies pay providers there.
